Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton L A, Hoover R, Haile R
Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA.
J Natl Cancer Inst. 1995 Nov 1;87(21):1622-9. doi: 10.1093/jnci/87.21.1622.
Mammographic images from women with a high proportion of epithelial and stromal breast tissues are described as showing high-density parenchymal patterns. Most past studies that noted an increase in breast cancer risk associated with mammographic parenchymal patterns showing high density either 1) lacked information on other breast cancer risk factors, 2) were too small, or 3) included insufficient follow-up time to adequately resolve persisting doubts whether mammographic features are "independent" measures of breast cancer risk and not a detection artifact.
The purpose of this study was twofold: 1) to evaluate the associations between mammographic features and other breast cancer risk factors and 2) to assess effects of mammographic features on breast cancer risk by time, age, and menopause status.
To address these questions, we analyzed detailed information from a large, nested case-control study with 16 years of follow-up. This study used information from both screening and follow-up phases of the Breast Cancer Detection Demonstration Project, a nationwide program that offered annual breast cancer screening for more than 280,000 women from 1973 to 1980. Mammographic features were assessed from the base-line screening mammographic examination for 1880 incident case subjects and 2152 control subjects. Control subjects were randomly selected from women of the same age and race as each case subject. Control subjects attended the same screening center as the case subject and were free of breast cancer at the case subject's date of diagnosis. Odds ratios (ORs) with 95% confidence intervals (CIs) provided estimates of the relative risk of breast cancer.
Mammographic features were associated with known breast cancer risk factors. However, the high-density parenchymal pattern effects were independent of family history, age at first birth, alcohol consumption, and benign breast disease. The increase risk for women with Wolfe's two high-density parenchymal patterns, P2 (OR = 3.2; 95% CI = 2.5-4.0) and Dy (OR = 2.9; 95% CI = 2.2-3.9), was explained primarily by measured percent of the breast with dense mammographic appearance. Compared with women with no visible breast density, women who had a breast density of 75% or greater had an almost fivefold increased risk of breast cancer (95% CI = 3.6-7.1). These effects persisted for 10 or more years and were noted for both premenopausal and postmenopausal women of all ages.
Of the breast cancer risk factors assessed in the participants, high-density mammographic parenchymal patterns, as measured by the proportion of breast area composed of epithelial and stromal tissue, had the greatest impact on breast cancer risk. Of the breast cancers in this study, 28% were attributable to having 50% or greater breast density.
乳腺上皮组织和间质组织比例较高的女性的乳腺钼靶图像显示为高密度实质模式。过去大多数指出乳腺钼靶实质模式显示高密度与乳腺癌风险增加相关的研究,要么1)缺乏其他乳腺癌风险因素的信息,要么2)样本量太小,要么3)随访时间不足,无法充分消除人们对乳腺钼靶特征是否是乳腺癌风险的“独立”指标而非检测假象的持续疑虑。
本研究的目的有两个:1)评估乳腺钼靶特征与其他乳腺癌风险因素之间的关联,2)按时间、年龄和绝经状态评估乳腺钼靶特征对乳腺癌风险的影响。
为解决这些问题,我们分析了一项大型巢式病例对照研究的详细信息,该研究有16年的随访期。本研究使用了乳腺癌检测示范项目筛查和随访阶段的信息,该项目是一个全国性项目,在1973年至1980年期间为超过280,000名女性提供年度乳腺癌筛查。从1880例发病病例受试者和2152例对照受试者的基线筛查乳腺钼靶检查中评估乳腺钼靶特征。对照受试者是从与每个病例受试者年龄和种族相同的女性中随机选择的。对照受试者与病例受试者在同一筛查中心就诊,并且在病例受试者诊断日期时没有患乳腺癌。具有95%置信区间(CI)的优势比(OR)提供了乳腺癌相对风险的估计值。
乳腺钼靶特征与已知的乳腺癌风险因素相关。然而,高密度实质模式的影响独立于家族史、初产年龄、饮酒和良性乳腺疾病。沃尔夫的两种高密度实质模式P2(OR = 3.2;95%CI = 2.5 - 4.0)和Dy(OR = 2.9;95%CI = 2.2 - 3.9)的女性患癌风险增加,主要是由乳腺钼靶显示致密外观的测量百分比来解释的。与乳腺无可见密度的女性相比,乳腺密度为75%或更高的女性患乳腺癌的风险几乎增加了五倍(95%CI = 3.6 - 7.1)。这些影响持续10年或更长时间,并且在所有年龄段的绝经前和绝经后女性中都有发现。
在参与者评估的乳腺癌风险因素中,通过上皮和间质组织组成的乳腺面积比例测量的高密度乳腺钼靶实质模式对乳腺癌风险影响最大。在本研究的乳腺癌病例中,28%可归因于乳腺密度达到50%或更高。